Methi

Names and identification

Language	Name
English	Methi

How does it work?

• 4-Hydroxyisoleucine (4-OHIle): Non-protein amino acid that increases glucose-induced insulin release in a glucose-concentration-dependent manner; stimulates glucose uptake by increasing surface GLUT4 via PI3K-dependent pathway in skeletal muscle.
• 4-OHIle anti-inflammatory: Ameliorates fatty acid-induced insulin resistance and inflammatory response in skeletal muscle cells.
• Diosgenin: Steroidal saponin serving as pharmaceutical precursor; inhibits aberrant crypt foci formation and induces apoptosis in colon cancer cells; anti-hypercholesterolemic and anti-inflammatory effects.
• Trigonelline: Alkaloid contributing to antidiabetic properties through multiple pathways.
• Soluble fiber (galactomannan): High fiber content slows gastric emptying and glucose absorption, contributing to glycemic control.
• Multi-tissue targeting: Pancreas (insulin secretion), skeletal muscle (glucose uptake via GLUT4), liver (gluconeogenesis reduction), adipose tissue (lipid metabolism), and gut (glucose absorption) are all modulated.
• Hormonal modulation: Influences testosterone levels and reproductive hormones, relevant to PCOS and testosterone deficiency applications.

Modern Research (Meta-Analysis)

Total PubMed publications found: 1948

Key Research Papers

1. A small plant with big benefits: Fenugreek (Trigonella foenum-graecum Linn.) for disease prevention and health promotion.

Authors: Nagulapalli Venkata Kalyan C, Swaroop Anand, Bagchi Debasis et al. Journal: Molecular nutrition & food research (2017) PMID: 28266134

Plant-derived natural products have long-standing utility toward treating degenerative diseases. It is estimated that about two-thirds of world population depend on traditional medicine for primary medical needs. Fenugreek (Trigonella foenum-graecum Linn.), a short-living annual medicinal plant belonging to Fabaceae family, is used extensively in various parts of the world as herb, food, spice, and traditional medicine. Fenugreek is considered as one of the oldest medicinal plants and its health-promoting effects have been cited in Ayurveda and traditional Chinese medicine. The investigations into the chemical composition and pharmacological actions have seen a renaissance in recent years. Extensive preclinical and clinical research have outlined the pharmaceutical uses of fenugreek as ant…

Keywords: Cancer, Diabetes, Health benefits, Phytochemicals, Trigonella foenum-graecum

2. Effects of

Authors: Faghfoori Zeinab, Javadivala Zeinab, Khalili Yeganeh et al. Journal: Immunopharmacology and immunotoxicology (2023) PMID: 37039783

Adjuvant therapies especially medicinal plants have gained lots of attention nowadays and have been consumed all over the world for treating different diseases particularly rheumatoid arthritis (RA). Recent animal studies have indicated the benefits of fenugreek in RA and indicate that it may be a therapeutic candidate in RA; nonetheless, no systematic review is available about fenugreek and RA. This paper systematically reviewed the existing studies about fenugreek and RA and plausible mechanisms…

Keywords: Trigonella, arthritis, rheumatoid, systematic review

3. Antidiabetic potential of fenugreek (

Authors: Sarker Dipto Kumer, Ray Pallobi, Dutta Ashit Kumar et al. Journal: Food science & nutrition (2024) PMID: 39479631

Fenugreek (…

Keywords: Trigonella foenum‐graecum, bioactive compounds, diabetes, fenugreek, molecular mechanism

4. Toxicological properties of fenugreek (Trigonella foenum graecum).

Authors: Ouzir Mounir, El Bairi Khalid, Amzazi Saaïd Journal: Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association (2016) PMID: 27498339

Fenugreek (Trigonella foenum graecum), used as traditional medicine and natural additive food, has been shown to exert significant antiatherogenic, antidiabetic, antianorexic, antioxidant, anticarcinogenic, antihyperlipidemic, galactogogue and anti-inflammatory effects in several human and animal models. Besides, several medicinal pharmaceutical and nutraceutical properties, fenugreek have toxic effects as well. The aim of this review is discuss the cumulative evidence, which suggests that consumption of fenugreek induced some serious toxicological side effects. In this review, many teratogenic effects of fenugreek, from congenital malformations to death, were reported in human, rodent, rabbit, and chick. Moreover, results obtained in rats, mice and rabbits show a testicular toxicity and a…

Keywords: Allergenicity, Anti-fertility effect, Antigenicity, Clinical toxicity, Fenugreek, Genotoxicity, LD50, Neurotoxicity, Teratogenicity, Toxicity

5. Trigonella foenum-graecum (fenugreek) differentially regulates antioxidant potential, photosynthetic, and metabolic activities under arsenic stress.

Authors: Ahmad Javed, Beg Md Amjad, Ali Arlene A et al. Journal: Ecotoxicology and environmental safety (2022) PMID: 36193587

Arsenic (As) contamination is continuously increasing in the groundwaters and soils around the world causing toxicity in the plants with a detrimental effect on physiology, growth, and yield. In a hydroponic system, thirty-day-old plants of Trigonella foenum-graecum were subjected to 0, 50, or 100 µM NaHAsO…

Keywords: Antioxidant capacity, GC-MS, Hill reaction activity, Metabolites, Oxidative stress, Trigonella foenum-graecum

6. Revisiting

Authors: Visuvanathan Theysshana, Than Leslie Thian Lung, Stanslas Johnson et al. Journal: Plants (Basel, Switzerland) (2022) PMID: 35684222

Fenugreek (…

Keywords: alkaloids, fenugreek, pharmacological potential, phytochemicals, saponins, trigonella foenum-graecum

7. 4-Hydroxyisoleucine from Fenugreek (Trigonella foenum-graecum): Effects on Insulin Resistance Associated with Obesity.

Authors: Avalos-Soriano Anaguiven, De la Cruz-Cordero Ricardo, Rosado Jorge L et al. Journal: Molecules (Basel, Switzerland) (2016) PMID: 27879673

Obesity and insulin resistance (IR) are interdependent multifactorial processes that cannot be understood separately. Obesity leads to systemic inflammation and increased levels of free fatty acids that provoke IR and lipotoxicity. At the same time, IR exacerbates adipose cell dysfunction, resulting in chronic inflammation and major lipotoxic effects on nonadipose tissues. 4-Hydroxyisoleucine (4-OHIle), a peculiar nonprotein amino acid isolated from fenugreek (…

Keywords: 4-hydroxyisoleucine, Trigonella foenum-graecum, fenugreek, insulinotropic

8. Effect of fenugreek (Trigonella foenum-graecum L.) intake on glycemia: a meta-analysis of clinical trials.

Authors: Neelakantan Nithya, Narayanan Madanagopal, de Souza Russell J et al. Journal: Nutrition journal (2014) PMID: 24438170

Fenugreek is a herb that is widely used in cooking and as a traditional medicine for diabetes in Asia. It has been shown to acutely lower postprandial glucose levels, but the long-term effect on glycemia remains uncertain. We systematically reviewed clinical trials of the effect of fenugreek intake on markers of glucose homeostasis…

What do recent clinical trials show?

• Fakhr L, Chehregosha F, Zarezadeh M and others 2023. Effects of fenugreek supplementation on the components of metabolic syndrome: A systematic review and dose-response meta-analysis of randomized clinical trials. Pharmacological research. PMID 36470549 · doi:10.1016/j.phrs.2022.106594
  Dose-response meta-analysis demonstrated beneficial effects of fenugreek supplementation on multiple metabolic syndrome components including glycemic and lipid parameters in randomized clinical trials.
• Kim J, Noh W, Kim A and others 2023. The Effect of Fenugreek in Type 2 Diabetes and Prediabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. International journal of molecular sciences. PMID 37762302 · doi:10.3390/ijms241813999
  Systematic review and meta-analysis confirmed beneficial effects on glycemic control parameters and lipid profiles in T2DM, supporting fenugreek as complementary diabetes therapy.
• Amiri Ardekani E, Parvizi MM, Zare R and others 2026. Exploring the Adverse Effects of Fenugreek in Humans: A Scoping Review. Iranian journal of medical sciences. PMID 41625343 · doi:10.30476/ijms.2025.106073.4017
  Scoping review of 60 articles (Jan 1990-Sep 2024): 14 clinical trials reported adverse effects, 23 reported none, 13 did not report. Most common adverse effect was mild gastrointestinal discomfort. No fatalities attributed to fenugreek use.
• Vajdi M, Noshadi N, Bonyadian A and others 2024. Therapeutic effect of fenugreek supplementation on type 2 diabetes mellitus: A systematic review and meta-analysis of clinical trials. Heliyon. PMID 39286181 · doi:10.1016/j.heliyon.2024.e36649
  Meta-analysis confirmed therapeutic benefit of fenugreek supplementation for T2DM management, with significant improvements in glycemic markers.
• Majeed M, Majeed S, Narayanan NK and others 2019. A pilot, randomized, double-blind, placebo-controlled trial to assess the safety and efficacy of a novel Boswellia serrata extract in the management of osteoarthritis of the knee. Phytotherapy research : PTR. PMID 30838706 · doi:10.1002/ptr.6338
  Patented fenugreek seed extract demonstrated both safety and efficacy in T2DM patients in a rigorous randomized double-blind placebo-controlled design.

1 further claim previously listed here could not be traced to a published paper and has been removed. An absence here means we could not identify the source, not that no work exists.

Recent safety updates

• Most common adverse effect: mild gastrointestinal discomfort (stomach upset, diarrhea, bloating) following oral consumption.
• Hypoglycemia risk: Due to possible hypoglycaemic effect, close monitoring of glycaemic control recommended in diabetic patients (EMA monograph warning).
• Allergic reactions: 10 case reports/series documented allergic reactions or hypersensitivity (cross-reactivity possible with chickpeas and other legumes).
• Maple syrup odor: Characteristic odor in sweat, urine, or skin of mothers and breastfed infants — can mimic maple syrup urine disease in neonatal screening.
• Suspected hypokalemia reported in some cases.
• Pregnancy contraindicated: Not recommended during pregnancy due to potential uterotonic effects. Unknown if it passes into breast milk.
• No known severe, serious, or moderate drug interactions documented, but caution with diabetes, asthma, and potassium-lowering medications.
• Hepatotoxicity: No clinically apparent liver injury cases despite widespread use; prospective studies show no effect on serum enzyme levels at therapeutic doses.
• Case report (2025): Ribociclib-induced hepatotoxicity potentially exacerbated by concurrent fenugreek supplement use, suggesting possible CYP-mediated interactions with oncology drugs.
• No fatalities attributed to fenugreek use in the literature.

What is it made of?

Key Active Markers

• Derived from constituent herbs (see individual herb profiles)
• Standardized on primary bioactive markers

Analytical Methods: HPLC fingerprinting, TLC (identity), LC-MS/MS (marker quantification)

Dosage forms and preparation

Dosage Forms: Churna (seed powder), Capsules, Tablets, Decoction, Sprouted seeds, Extract (hydroalcoholic), Mucilage gel, Topical paste/hair mask

Standard Dosage: 5-30 g seed powder per day (diabetes management); 500-1000 mg standardized extract twice daily; 5-10 g soaked/sprouted seeds daily

Bioavailability: 4-Hydroxyisoleucine has good oral bioavailability (~60%). Diosgenin is lipophilic with moderate absorption enhanced by lipid co-administration. Galactomannan fiber (50% of seed) is not absorbed but slows glucose and lipid absorption, providing therapeutic benefit. Trigonelline has good water solubility and oral bioavailability (~70%). Steroidal saponins undergo GI hydrolysis before absorption.

Optimal Timing: 30 minutes before meals for glycemic control (fiber and 4-hydroxyisoleucine need time to form gel); soaked seeds in morning for general health; topical paste overnight for hair health

Standardized Extract: Standardized seed extract (10:1) with minimum 40% galactomannan and 4% steroidal saponins (as diosgenin equivalents). 4-Hydroxyisoleucine-enriched extract (minimum 20% 4-HI) for targeted glycemic products. Defatted seed powder for fiber supplementation. Diosgenin-rich extract (minimum 10%) for hormonal applications.

Shelf Life: Whole seeds: 36 months. Ground powder: 18 months. Extract capsules: 24 months. Mucilage gel: 12 months with preservative.

Storage: Whole seeds in cool, dry conditions at room temperature. Ground powder in airtight containers below 25 deg C. Extract capsules in blister packs with desiccant. Mucilage gel refrigerated at 2-8 deg C after opening.

Marker Compounds: 4-Hydroxyisoleucine, Diosgenin, Trigonelline, Galactomannan, Sotolon, Yamogenin, Gitogenin, Protodioscin

Extraction Methods

• Aqueous extraction (soaking/decoction)
• Hydroalcoholic extraction (50-70% ethanol)
• Defatting with hexane followed by ethanol extraction
• Enzymatic extraction for galactomannan
• Supercritical CO2 for diosgenin-enriched extract
• Cold water extraction for mucilage

Synergistic Combinations

• Karela/Bitter gourd (anti-diabetic synergy)
• Gudmar/Gymnema (blood sugar management)
• Jamun (anti-diabetic combination)
• Shunthi (digestive and metabolic)
• Haridra (anti-inflammatory and metabolic syndrome)
• Dalchini/Cinnamon (insulin sensitization)